Published in PLoS One on July 23, 2010
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration. Vaccines (Basel) (2015) 0.84
Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysis. AIDS Behav (2014) 0.80
Will HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensation. PLoS One (2014) 0.78
Complex immune correlates of protection in HIV-1 vaccine efficacy trials. Immunol Rev (2017) 0.76
Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination. AIDS Care (2015) 0.75
Operations research in global health: a scoping review with a focus on the themes of health equity and impact. Health Res Policy Syst (2017) 0.75
Fitting HIV Prevalence 1981 Onwards for Three Indian States Using the Goals Model and the Estimation and Projection Package. PLoS One (2016) 0.75
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30
Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol (1999) 6.25
The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect (2008) 5.98
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science (1994) 2.98
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS (2003) 2.60
Potential public health impact of imperfect HIV type 1 vaccines. J Infect Dis (2005) 1.80
Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis (2004) 1.79
Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci (1991) 1.50
The impact of an AIDS vaccine in developing countries: a new model and initial results. Health Aff (Millwood) (2007) 1.48
Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980-2005. Cad Saude Publica (2007) 1.46
Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. J Acquir Immune Defic Syndr (2007) 1.00
How can we calculate the "E" in "CEA"? AIDS (2008) 0.99
[Epidemiologic aspects of racial inequalities in health in Brazil]. Cad Saude Publica (2005) 0.95
Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics. AIDS (1998) 0.93
Temporal trends of HIV-related risk behavior among Brazilian military conscripts, 1997-2002. Clinics (Sao Paulo) (2005) 0.89
Reconstructing the AIDS epidemic among injection drug users in Brazil. Cad Saude Publica (2006) 0.88
Cost effectiveness and delivery study for future HIV vaccines. AIDS (2005) 0.80
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73
Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001. AIDS (2003) 5.88
Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. Int J Drug Policy (2012) 5.68
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009. Sex Transm Infect (2010) 3.14
Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med (2011) 2.37
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One (2010) 2.30
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99
Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One (2011) 1.98
The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One (2009) 1.97
What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect (2010) 1.92
Benefits and costs of expanding access to family planning programs to women living with HIV. AIDS (2009) 1.60
Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One (2011) 1.60
Estimates of HIV incidence from household-based prevalence surveys. AIDS (2010) 1.59
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy. Sex Transm Infect (2010) 1.59
Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services. PLoS Med (2011) 1.58
Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS One (2011) 1.56
Methods used in the Lives Saved Tool (LiST). BMC Public Health (2011) 1.48
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. Lancet (2010) 1.46
Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect (2010) 1.45
Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate. Braz J Infect Dis (2011) 1.44
The estimated burden of HIV/AIDS in Uganda, 2005-2010. AIDS (2008) 1.34
Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff (Millwood) (2009) 1.33
The past, present and future of HIV, AIDS and resource allocation. BMC Public Health (2009) 1.24
Estimation of antiretroviral therapy coverage: methodology and trends. Curr Opin HIV AIDS (2010) 1.21
The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV. AIDS (2014) 1.18
Factors influencing global antiretroviral procurement prices. BMC Public Health (2009) 1.16
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries. AIDS Res Treat (2011) 1.15
Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ (2012) 1.14
Bottlenecks and recommendations for the incorporation of new technologies in the tuberculosis laboratory network in Brazil. J Bras Pneumol (2013) 1.07
Estimating future trends in paediatric HIV. AIDS (2014) 1.07
Changes in the distribution of high-risk births associated with changes in contraceptive prevalence. BMC Public Health (2013) 1.05
The cost and impact of male circumcision on HIV/AIDS in Botswana. J Int AIDS Soc (2009) 1.02
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (2014) 1.01
Where are the gaps? The effects of HIV-prevention interventions on behavioral change. Stud Fam Plann (2004) 1.01
Under-5 mortality due to HIV: regional levels and 1990-2009 trends. Sex Transm Infect (2010) 0.99
Tuberculosis and AIDS co-morbidity in Brazil: linkage of the tuberculosis and AIDS databases. Braz J Infect Dis (2009) 0.94
Redefining the HIV epidemic in Nigeria: from national to state level. AIDS (2014) 0.90
Embracing different approaches to estimating HIV incidence, prevalence and mortality. AIDS (2014) 0.88
Confirming the impact of HIV/AIDS epidemics on household vulnerability in Asia: the case of Cambodia. AIDS (2008) 0.88
Factors associated with colposcopy-histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio De Janeiro, Brazil. PLoS One (2011) 0.87
The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand. Vaccine (2011) 0.87
Improving estimates of children living with HIV from the Spectrum AIDS Impact Model. AIDS (2017) 0.87
Modelling the potential impact and cost of scaling-up male circumcision in resource poor settings: A case of Uganda. Afr J AIDS Res (2013) 0.86
Bipolar tissue sealant device decreases hemoglobin loss in multilevel spine surgery. Transfusion (2012) 0.86
Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges. BMC Public Health (2013) 0.86
Randomized clinical trial comparing the pharmacokinetics of standard- and increased-dosage lopinavir-ritonavir coformulation tablets in HIV-positive pregnant women. Antimicrob Agents Chemother (2014) 0.85
Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. AIDS (2008) 0.83
Using HIV surveillance data: recent experiences and avenues for the future. AIDS (2005) 0.83
Family planning programs in 2004: new assessments in a changing environment. Int Fam Plan Perspect (2007) 0.82
Aging with HIV: a practical review. Braz J Infect Dis (2013) 0.82
Vaccine research, development, and innovation in Brazil: a translational science perspective. Vaccine (2013) 0.82
Modelling the demographic impact of AIDS. J Health Popul Nutr (2002) 0.81
Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects. Vaccine (2012) 0.80
The economic impacts of HIV/AIDS on households and economies. AIDS (2008) 0.79
[Performance by cytology and hybrid capture II in screening for high-grade squamous intraepithelial lesions in women with HIV]. Cad Saude Publica (2011) 0.77
Low incidence of colonization and no cases of disseminated Mycobacterium avium complex infection (DMAC) in Brazilian AIDS patients in the HAART era. Braz J Infect Dis (2002) 0.77
Socially adjusted synchrony in the activity profiles of common marmosets in light-dark conditions. Chronobiol Int (2013) 0.77
Novel no-touch technique of harvesting the saphenous vein for coronary artery bypass grafting. Arq Bras Cardiol (2008) 0.77
Antiretroviral therapy needs: the effect of changing global guidelines. Sex Transm Infect (2010) 0.77
Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation. Anesthesiology (2005) 0.77
Short communication: neutralizing antibodies in HIV-1-infected Brazilian individuals. AIDS Res Hum Retroviruses (2012) 0.76
Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe. AIDS (2017) 0.76
Correction: Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0. PLoS One (2017) 0.75
Correction: Impact of Replacing Smear Microscopy with Xpert MTB/RIF for Diagnosing Tuberculosis in Brazil: A Stepped-Wedge Cluster-Randomized Trial. PLoS Med (2015) 0.75
Correction: The Cost of Voluntary Medical Male Circumcision in South Africa. PLoS One (2017) 0.75
Linking high parity and maternal and child mortality: what is the impact of lower health services coverage among higher order births? BMC Public Health (2013) 0.75
Correction: Estimating Client Out-of-Pocket Costs for Accessing Voluntary Medical Male Circumcision in South Africa. PLoS One (2017) 0.75
Putting the burden of HIV in context. AIDS (2013) 0.75
Low dead space syringes: authors' response. Int J Drug Policy (2012) 0.75
Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. PLoS One (2016) 0.75
Correction: What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One (2016) 0.75
Correction: Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program. PLoS One (2016) 0.75
Urgent call for action: avoiding spread and re-urbanisation of yellow fever in Brazil. Mem Inst Oswaldo Cruz (2017) 0.75
Informing scale-up and resource allocation: the use of economic analysis. AIDS (2008) 0.75
Improvements in Spectrum's fit to program data tool. AIDS (2017) 0.75
Progress toward the Goals of FP2020. Stud Fam Plann (2017) 0.75
Resource requirements to fight HIV/AIDS in Latin America and the Caribbean. AIDS (2002) 0.75
30 years after HIV identification: where to from here? Expert Rev Anti Infect Ther (2011) 0.75
AIDS research in Brazil. AIDS (2005) 0.75
Combining evidence for access to and benefits from antiretroviral treatment to inform planning. AIDS (2008) 0.75